LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma-Reference-Cited by-同舟云学术

LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma

Published:2018-10-03 Issue:4 Volume:54 Page:625-628
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

dos Santos Kelli Borges^ORCID,Costa Luciano José Megale^ORCID,Bettarello Gustavo,da Matta Abreu Marcus,Mayrink Graziela Toledo Costa,Mota Mariza Aparecida,Ribeiro Luiz Cláudio,Pereira Juliana,Hallack Neto Abrahão Elias

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0349-4.pdf

Reference11 articles.

1. Santos KB, Pereira J, Atalla A, Costa LucianoJ, Neto AEH. The use of lomustine in combination with etoposide, cytarabine and melphalan in a brief conditioning for auto-HSCT in patients with lymphoma: the optimal dose. Bone Marrow Transplant. 2014;49:1239–40.

2. Damaj G, Cornillon J, Bouabdallah K, Gressin R, Vigouroux S, Gastinne T, et al. Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review. Bone Marrow Transplant. 2017;52:941–9.

3. Chao NJ, et al. A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma. Cancer . 1995;75:1354–9.

4. Ramzi M, Mohamadian M, Vojdani R, Dehghani M, Nourani H, Zakerinia M, et al. Autologous noncryopreserved hematopoietic stem cell transplant with CEAM as a modified conditioning regimen in patients with Hodgkin lymphoma: a single-center experience with a new protocol. Exp Clin Transplant. 2012;10:163–7.

5. Stuart MJ, Chao NS, Horning SJ, Wong RM, Negrin RS, Johnston LJ, et al. Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin’s disease. Biol Blood Marrow Transplant. 2001;7:552–60.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gonadotropic Axis, Bone Mass, and Sarcopenia Assessment After Autologous Hematopoietic Stem Cell Transplantation for Lymphoma;Clinical Transplantation;2024-07

2. Outcome of CBV (Carmustine, Cyclophosphamide, Etoposide) Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma: A Retrospective Study from a Tertiary Cancer Center in South India;Indian Journal of Medical and Paediatric Oncology;2022-02-02

3. Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients;Bone Marrow Transplantation;2021-11-29

4. Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group;HemaSphere;2020-01-10

5. LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation;Frontiers in Oncology;2019-09-10